New Rheumatoid Arthritis Treatments for ‘Old’ Patients: Results of a Systematic Review

INTRODUCTION: In the last 20 years, biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs) have become available for treating rheumatoid arthritis (RA), and a treat-to-target strategy has been introduced. We hypothesise that these advances should have resulted in changes to t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Adv Ther
Autors principals: Caporali, Roberto, Fakhouri, Walid K. H., Nicolay, Claudia, Longley, Harriet J., Losi, Serena, Rogai, Veronica
Format: Artigo
Idioma:Inglês
Publicat: Springer Healthcare 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7444401/
https://ncbi.nlm.nih.gov/pubmed/32705531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01435-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars